CN115778847A - Jelly-like eye shadow and preparation method thereof - Google Patents
Jelly-like eye shadow and preparation method thereof Download PDFInfo
- Publication number
- CN115778847A CN115778847A CN202211660883.XA CN202211660883A CN115778847A CN 115778847 A CN115778847 A CN 115778847A CN 202211660883 A CN202211660883 A CN 202211660883A CN 115778847 A CN115778847 A CN 115778847A
- Authority
- CN
- China
- Prior art keywords
- eye shadow
- oil
- powder
- jelly
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000000843 powder Substances 0.000 claims abstract description 87
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000002562 thickening agent Substances 0.000 claims abstract description 27
- 238000004040 coloring Methods 0.000 claims abstract description 25
- 239000003921 oil Substances 0.000 claims abstract description 24
- 239000010445 mica Substances 0.000 claims abstract description 19
- 229910052618 mica group Inorganic materials 0.000 claims abstract description 19
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 18
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 18
- 239000003974 emollient agent Substances 0.000 claims abstract description 15
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 15
- VEUACKUBDLVUAC-UHFFFAOYSA-N [Na].[Ca] Chemical compound [Na].[Ca] VEUACKUBDLVUAC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003381 stabilizer Substances 0.000 claims abstract description 13
- 239000003906 humectant Substances 0.000 claims abstract description 12
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910001887 tin oxide Inorganic materials 0.000 claims abstract description 12
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims abstract description 9
- ULGYAEQHFNJYML-UHFFFAOYSA-N [AlH3].[Ca] Chemical compound [AlH3].[Ca] ULGYAEQHFNJYML-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 26
- 235000019198 oils Nutrition 0.000 claims description 22
- 239000007788 liquid Substances 0.000 claims description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 14
- 229920001577 copolymer Polymers 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 229920002148 Gellan gum Polymers 0.000 claims description 10
- 239000000216 gellan gum Substances 0.000 claims description 10
- 235000010492 gellan gum Nutrition 0.000 claims description 10
- 239000000945 filler Substances 0.000 claims description 8
- 238000011049 filling Methods 0.000 claims description 8
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical group OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 claims description 7
- 229920001214 Polysorbate 60 Polymers 0.000 claims description 7
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 claims description 7
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 claims description 7
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 claims description 7
- 229940113124 polysorbate 60 Drugs 0.000 claims description 7
- 229940057429 sorbitan isostearate Drugs 0.000 claims description 7
- ZEYHEAKUIGZSGI-UHFFFAOYSA-N 4-methoxybenzoic acid Chemical compound COC1=CC=C(C(O)=O)C=C1 ZEYHEAKUIGZSGI-UHFFFAOYSA-N 0.000 claims description 6
- 235000018330 Macadamia integrifolia Nutrition 0.000 claims description 6
- 240000000912 Macadamia tetraphylla Species 0.000 claims description 6
- 235000003800 Macadamia tetraphylla Nutrition 0.000 claims description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 239000003240 coconut oil Substances 0.000 claims description 6
- 235000019864 coconut oil Nutrition 0.000 claims description 6
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 6
- -1 polydimethylsiloxane Polymers 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 5
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 230000003078 antioxidant effect Effects 0.000 claims description 4
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical group OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical group [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 claims description 3
- 241001673966 Magnolia officinalis Species 0.000 claims description 3
- 235000019482 Palm oil Nutrition 0.000 claims description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 3
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 3
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 239000004359 castor oil Substances 0.000 claims description 3
- 235000019438 castor oil Nutrition 0.000 claims description 3
- 239000002270 dispersing agent Substances 0.000 claims description 3
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 claims description 3
- 229940093471 ethyl oleate Drugs 0.000 claims description 3
- 125000005456 glyceride group Chemical group 0.000 claims description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 3
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 3
- 229940074046 glyceryl laurate Drugs 0.000 claims description 3
- 239000008169 grapeseed oil Substances 0.000 claims description 3
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 3
- 229940100554 isononyl isononanoate Drugs 0.000 claims description 3
- 229940119170 jojoba wax Drugs 0.000 claims description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 3
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 3
- 239000010487 meadowfoam seed oil Substances 0.000 claims description 3
- 239000010466 nut oil Substances 0.000 claims description 3
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000002540 palm oil Substances 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 claims description 3
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 3
- 239000003813 safflower oil Substances 0.000 claims description 3
- 235000005713 safflower oil Nutrition 0.000 claims description 3
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 3
- 235000010234 sodium benzoate Nutrition 0.000 claims description 3
- 239000004299 sodium benzoate Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000002639 sodium chloride Nutrition 0.000 claims description 3
- 235000020238 sunflower seed Nutrition 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- 229960000281 trometamol Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 241001506047 Tremella Species 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- 229940057910 shea butter Drugs 0.000 claims description 2
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 19
- 235000015110 jellies Nutrition 0.000 abstract description 7
- 239000008274 jelly Substances 0.000 abstract description 7
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 abstract description 4
- 239000004519 grease Substances 0.000 abstract description 3
- 239000002932 luster Substances 0.000 abstract description 3
- 239000011248 coating agent Substances 0.000 abstract description 2
- 238000000576 coating method Methods 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 15
- 239000000203 mixture Substances 0.000 description 13
- 230000006641 stabilisation Effects 0.000 description 12
- 238000011105 stabilization Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 9
- 239000002245 particle Substances 0.000 description 7
- 230000003020 moisturizing effect Effects 0.000 description 6
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- IMRGQGFAAGFVNH-UHFFFAOYSA-N 11-decyltetracosan-11-ol Chemical compound C(CCCCCCCCC)C(CCCCCCCCCCCCC)(O)CCCCCCCCCC IMRGQGFAAGFVNH-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000002146 bilateral effect Effects 0.000 description 2
- 238000005282 brightening Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000000216 zygoma Anatomy 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- FKIQSOGFDBALHA-UHFFFAOYSA-L aluminum trimagnesium potassium dioxido(oxo)silane oxygen(2-) difluoride Chemical compound [O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O FKIQSOGFDBALHA-UHFFFAOYSA-L 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940085262 cetyl dimethicone Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Polymers [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical group CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
The application discloses a jelly-shaped eye shadow and a preparation method thereof, wherein the jelly-shaped eye shadow comprises the following components in percentage by mass: 10-18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica; coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, black iron oxide, at least part of the surface of which is coated by silica; 0.5 to 3 percent of water-based thickening agent; 0.2-1% of emollient oil; oil-in-water type emulsifier, 0.02-0.2% stabilizer, 0.02% -0.3%; 4% -6% of a humectant; 65 to 78 percent of water. The pearly luster powder and the coloring powder are uniformly dispersed by the appropriate proportion of the water-based thickener, the skin-moistening grease, the oil-in-water emulsifier and the water, so that the effect of shining when the coating is less can be achieved; the eye shadow forms a jelly shape, does not drip after being applied, and avoids stains caused by dripping after being used.
Description
Technical Field
The application belongs to the technical field of daily cosmetics, and particularly relates to a jelly-shaped eye shadow and a preparation method thereof.
Background
The eye shadow is a cosmetic applied to the upper eyelid and the tail of the eye, has high saturation, and can make the eyes look uneven.
Common eye shadows are generally powder and ointment. The eye shadow of the powder is easy to fly powder, the eye shadow of the ointment is sticky and easy to be stuck into a line, and the experience of consumers is reduced. In addition, in the use process, after the eye shadow of the powder and the ointment falls, stains are easily caused on clothes and the like, so that the eye shadow needs to be improved.
Disclosure of Invention
In view of this, the present application provides a jelly-like eye shadow and a preparation method thereof, and aims to provide a new dosage form of the eye shadow which is fresh and cool and does not stick to greasy.
In a first aspect, embodiments of the present application provide a jelly-like eye shadow, which includes the following components in percentage by mass:
10-18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica;
coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, black iron oxide, at least part of the surface of which is coated by silica;
0.5 to 3 percent of water-based thickening agent;
0.2-1% of emollient oil;
0.02-0.2% of oil-in-water type emulsifier
0.02 to 0.3 percent of stabilizer;
4 to 6 percent of humectant;
65 to 78 percent of water.
According to an embodiment of one aspect of the present application, the pearlescent powder comprises 80% to 92% of calcium sodium borosilicate and 8% to 20% of mica, based on the total weight of the pearlescent powder.
According to an embodiment of one aspect of the present application, the colored powder comprises 35% to 45% of titanium dioxide dust having a part of its surface coated with silica, based on the total weight of the colored powder.
According to an embodiment of one aspect of the application, the aqueous thickener is selected from gellan gum, carrageenan, PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether or a combination thereof.
According to an embodiment of one aspect of the present application, the aqueous thickener comprises 60% to 75% gellan gum based on the total weight of the aqueous thickener.
According to an embodiment of one aspect of the present application, the mass ratio of gellan gum to PEG-240/HDI copolymer bis-decyltetradecylpolyether-20 ether is (25-32) to 50, optionally 29.94:50.
according to an embodiment of one aspect of the application, the oil-in-water emulsifier is selected from hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate or a combination thereof.
According to an embodiment of one aspect of the application, the mass ratio of the hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, the polysorbate-60 and the sorbitan isostearate is (42-46): (2-4): 3, and can be selected from 44.
According to an embodiment of one aspect of the present application, the emollient oil is selected from the group consisting of polydimethylsiloxane, macadamia nut ethyl oleate, hydrogenated coconut oil glycerides, glyceryl laurate, isononyl isononanoate, hydrogenated polyisobutene, sunflower seed oil, safflower seed oil, jojoba oil, castor oil, coconut oil, grape seed oil, shea butter, meadowfoam seed oil, macadamia nut oil, olive oil, palm oil, or combinations thereof.
According to an embodiment of one aspect of the application, the preservative is selected from phenoxyethanol, caprylyl glycol, sodium benzoate, glyceryl caprylate, anisic acid, magnolia bark extract or a combination thereof.
According to an embodiment of one aspect of the present application, the humectant is selected from glycerin, propylene glycol, 1, 3-butylene glycol, trehalose, tremella polysaccharide, lodestone, sodium hyaluronate, or a combination thereof.
According to an embodiment of one aspect of the application, the stabilizer is selected from the group consisting of anhydrous calcium chloride, potassium laurate, magnesium sulfate, sodium chloride, potassium chloride, tromethamine, triethanolamine or a combination thereof.
According to an embodiment of one aspect of the application, the jelly-like eye shadow further comprises 0.5% -1.5% of a powder dispersant and/or 0.02% -0.3% of an antioxidant.
In a second aspect, an embodiment of the present application provides a method for preparing a jelly-like eye shadow, including:
providing the components and component amounts of an eye shadow according to the first aspect;
preparing a filling material: mixing and dispersing 10% -18% of pearl powder and 5% -12% of coloring powder to obtain uniform filler;
preparing a functional material in a liquid state: mixing 0.5-3% of aqueous thickening agent, 0.2-1% of emollient oil, 0.02-0.2% of oil-in-water emulsifier, 0.02-0.3% of stabilizer, 4-6% of humectant and 65-78% of water at a predetermined temperature to obtain a liquid functional material;
preparing an eye shadow: mixing and emulsifying the filling material and the functional material in the liquid state to obtain the eye shadow;
optionally, the preparation of the filler and the preparation of the functional material in a liquid state are performed simultaneously.
Compared with the prior art, the application has at least the following beneficial effects:
the eye shadow provided by the embodiment of the application comprises pearl powder, coloring powder, an aqueous thickening agent, emollient grease, an oil-in-water emulsifier and the like, wherein the pearl powder and the coloring powder are synergistically brightened by titanium dioxide powder partially coated with silica on the surface, so that the brightening effect of the eye shadow is improved, and after silica is doped, the pearl powder and the coloring powder have good dispersibility, so that the color is more uniform, and the powder is not agglomerated; the appropriate proportion of the water-based thickener, the emollient oil, the oil-in-water emulsifier and the water uniformly disperses the pearlescent powder and the coloring powder, and the effect of shining when the coating is less can be achieved; the eye shadow forms a jelly shape, does not drip after being applied, and avoids stains caused by dripping after being used.
Drawings
FIG. 1 shows a jelly-like eye shadow of an embodiment;
fig. 2 shows a comparative example non-jelly-like eye shadow.
Detailed Description
In order to make the application purpose, technical solution and beneficial technical effects of the present application clearer, the present application is further described in detail with reference to the following embodiments. It should be understood that the embodiments described in this specification are only for the purpose of explaining the present application and are not intended to limit the present application.
For the sake of brevity, only some numerical ranges are explicitly disclosed herein. However, any lower limit may be combined with any upper limit to form ranges not explicitly recited; and any lower limit may be combined with any other lower limit to form a range not explicitly recited, and similarly any upper limit may be combined with any other upper limit to form a range not explicitly recited. Also, although not explicitly recited, each point or individual value between endpoints of a range is encompassed within the range. Thus, each point or individual value can form a range not explicitly recited as its own lower or upper limit in combination with any other point or individual value or in combination with other lower or upper limits.
In the description of the present application, it is to be noted that, unless otherwise specified, "above" and "below" are inclusive of the present number, and "plural" of "one or more" means two or more.
The above summary of the present application is not intended to describe each disclosed embodiment or every implementation of the present application. The following description more particularly exemplifies illustrative embodiments. At various points throughout this application, guidance is provided through lists of examples, which examples can be used in various combinations. In each instance, the list is merely a representative group and should not be construed as exhaustive.
The eye shadow is a makeup cosmetic which is applied to eyelids and corners of eyes to produce shadow and color contrast and to show a three-dimensional aesthetic feeling. Eye shadows are formulated similarly to foundations, but are more colorful and tend to have additional luster, typically with the addition of a variety of coloring powders as well as pearlescent powders. Thus, in the prior art, the main dosage forms of eye shadow are solid powder eye shadow and liquid-cream eye shadow.
In the related technology, the solid powder eye shadow is easy to fly powder, the liquid-paste eye shadow is sticky, and the eye shadow is easy to be stuck into a line after being applied for a certain time.
The inventor provides an eye shadow with jelly texture through deep thinking and a large number of experiments, and avoids the problems that powder is easy to fly from powder eye shadows and ointment eye shadows are easy to block eye lines.
Jelly-like eye shadow
The embodiment of the application provides a jelly-like eye shadow which comprises the following components in percentage by mass:
10% -18% of pearl powder, which contains at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica;
coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, black iron oxide, at least part of the surface of which is coated by silica;
0.5 to 3 percent of water-based thickening agent;
0.2-1% of emollient oil;
0.02-0.2% of oil-in-water emulsifier
0.02% -0.3% of stabilizer;
4 to 6 percent of humectant;
65 to 78 percent of water.
According to the embodiment of the application, the jelly-shaped eye shadow comprises components such as pearl powder, coloring powder, aqueous thickening agent, emollient oil, oil-in-water emulsifier and the like, and the jelly-shaped eye shadow does not fade and drip immediately after being applied, and is free of stains and smudges in the using process.
According to the embodiments of the present application, the jelly-like eye shadow of the present application is not easy to collapse even when external force is applied, although it is jelly-like and has no slicing property. However, when the jelly-like eye shadow was placed in a 200ml container at about 100g and shaken vigorously up and down about 10 times, the gel collapsed and partially crushed. Have a degree of viscosity that is neither a soft liquid nor a solid, irregular, gelatinous mass. When the adhesive tape is peeled off after being attached to a medium with a smooth surface, such as glass, clothes and metal, a part of the adhesive tape can be removed without leaving any mark, so that no stain is generated during use.
In some embodiments, the jelly-like eye shadow further comprises a powder of one or more of silica, talc, and polymethylsilsesquioxane. Illustratively, by adding the silica powder, the eye shadow has certain concealing force, the smooth feeling of the skin can be increased, the skin is made up to be smooth, and meanwhile, the overall dispersibility of other powder in the eye shadow can be enhanced, and the agglomeration is avoided.
In some embodiments, the pearlescent powder comprises 80% to 92% sodium calcium borosilicate and 8% to 20% mica, based on the total weight of the pearlescent powder.
By way of example, synthetic fluorophlogopite mica may be selected for use herein. By way of example, sodium calcium borosilicate can increase the shining gloss of eye shadow, has a blurring effect and a light protection effect, and can enable the eye shadow to effectively achieve a halation effect; in addition, the calcium sodium borosilicate has the effect of low oil absorption, can effectively regulate sebum secreted grease, and improves the durability of eye shadow. The calcium sodium borosilicate can also effectively weaken wrinkles and blemishes and make the skin color more uniform.
In some embodiments, the colored powder comprises 35% to 45% of titanium dioxide dust partially surface-coated with silica, based on the total weight of the colored powder.
According to the embodiment of the present application, the titanium dioxide powder partially coated with silica is used to improve the dispersibility of the coloring powder and the dispersibility of the pearl powder by increasing the silica, and at the same time, to increase the natural light sensation of the eye shadow
In some embodiments, the colored powder is selected from titanium dioxide, iron yellow, iron red, tin oxide, iron oxide black, polydimethylsiloxane-modified titanium dioxide, and aluminum hydroxide-modified red 30, or combinations thereof.
According to the embodiment of the application, the stability of the color of the eye shadow is enhanced in different modes by adding the organic coloring powder and the inorganic coloring powder, and meanwhile, the natural light sensation of the eye shadow is enhanced by adding the tin oxide.
In some implementations, the pearlescent powder and the coloring powder each independently have an average particle diameter (D50) of 10 to 100um. The use of the pearl powder and the coloring powder having different particle diameters makes it possible to make the eye shadow exhibit different glittering effects.
The desired particle size can be obtained by conventional methods, for example by sieving or sedimentation. The average particle diameter (D50) was measured by a Malvern particle diameter analyzer (model: mastersizer 3000 laser diffraction particle size analyzer) from Malvern Pasnake.
In some embodiments, the colored powder has particles of about 20 to about 40 μm.
In some embodiments, the jelly-like eye shadow comprises a first mica pearlescent mixture, the first mica pearlescent mixture consisting of mica, titanium dioxide, and iron oxide black, the mass ratio of mica, titanium dioxide, and iron oxide black being 43:7:50.
in some embodiments, the jelly-like eye shadow comprises a second mica pearlescent mixture, the second mica pearlescent mixture is composed of mica, titanium dioxide and tin oxide, and the mass ratio of the mica to the titanium dioxide to the tin oxide is 34:65.5:0.5.
in some embodiments, the jelly-like eye shadow comprises a glass pearlescent mixture consisting of calcium sodium borosilicate: titanium dioxide: tin oxide composition, calcium sodium borosilicate: titanium dioxide: the mass ratio of the tin oxide is 87.9:10.7:1.4.
in some embodiments, the pearlescent powder and the coloring powder in the jelly-like eye shadow are comprised of a first mica pearlescent mixture, a second mica pearlescent mixture, and a glass pearlescent mixture.
In some embodiments, the jelly-like eye shadow comprises 1% to 2% of the first micaceous pearlescent mixture, 2% to 3% of the second micaceous pearlescent mixture, and 16% to 17% of the glass pearlescent mixture.
According to the embodiment of the application, the pearl powder and the coloring powder in a proper mass ratio are combined, so that the pearl effect of the eye shadow can be improved, and the eye shadow can have better brightening and anti-darkening effects; the pearl powder and the coloring powder in a proper mass ratio have synergistic effect, and have the effects of improving the eye shadow saturation, improving the concave-convex feeling and shining the luster.
In some embodiments, the aqueous thickener is selected from gellan gum, carrageenan, PEG-240/HDI copolymer bis-decyltetradecyl alcohol polyether-20 ether, or a combination thereof.
According to the embodiment of the application, the thickening agent plays an important role in thickening, stability and rheological property of the oil-in-water jelly-shaped eye shadow; by using the thickener, it is possible to give it a good consistency, as well as excellent spreadability and spreadability. By adding the thickener, the viscosity of the oil-in-water emulsion can be adjusted, and the skin-sticking property and the use feeling can be enhanced. The thickening agent can improve the viscosity of a system and also has an emulsifying function.
In some embodiments, the aqueous thickener comprises 60% to 75% gellan gum based on the total weight of the aqueous thickener. The cold glue with the weight ratio is used for forming a jelly-shaped eye shadow.
In some embodiments, the mass ratio of gellan gum to PEG-240/HDI copolymer bis-decyltetradecylpolyether-20 ether is (25-32): 50, optionally 29.94:50. by adding the thickener in the above ratio, a relatively stable gel-like eye shadow can be provided.
In some embodiments, the oil-in-water emulsifier is selected from hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate, or combinations thereof.
According to the embodiments of the present application, the above emulsifier provides excellent emulsification effect, can form a milky emulsion by mixing oil and water together, or form a jelly-like emulsion by matching other components, and has excellent dispersibility and stability, refreshing and comfort in use, no greasy feeling, and improved consistency, as well as excellent spreadability and ductility.
In some embodiments, the mass ratio of hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer to polysorbate-60 to sorbitan isostearate is (42-46): 2-4): 3, optionally 44. The above mass range can promote the jelly-like formation of the components in the eye shadow and promote the stability and transportability thereof.
In some embodiments, the emollient oil is selected from the group consisting of dimethicone, macadamia nut ethyl oleate, hydrogenated coconut oil glycerides, glyceryl laurate, isononyl isononanoate, hydrogenated polyisobutylene, sunflower seed oil, safflower seed oil, jojoba oil, castor oil, coconut oil, grape seed oil, shea oil, meadowfoam seed oil, macadamia nut oil, olive oil, palm oil, or combinations thereof.
According to the embodiment of the application, the type of the skin moistening oil is not particularly limited, the oil phase components can be selected according to requirements, the oil phase components have good permeability to skin, the oil phase components have good effect on increasing loose softness of the eye shadow, and the eye shadow moisturizing oil can be matched with other components to further improve the moistening property, the fluidity, the repairability and the extensibility of the eye shadow and ensure the moisturizing and skin-adhering effect of the eye shadow.
Illustratively, the polydimethylsiloxane can increase the chroma, reduce the gloss, control and absorb sebum, adjust viscosity, increase smooth feeling, have powder texture, do not close pores and improve the dispersibility of powder.
In some embodiments, the preservative is selected from phenoxyethanol, caprylyl glycol, sodium benzoate, glyceryl caprylate, anisic acid, magnolia bark extract, or combinations thereof. The preservative is well compatible with other substances, and the shelf life of the eye shadow can be prolonged by adding the preservative.
In some embodiments, the humectant is selected from caprylin, ethylhexyl glyceryl dimethicone, phenyl dimethicone, cetyl dimethicone, malic diisostearate, or combinations thereof.
According to the embodiment of the application, the moisturizing agent has strong moisturizing performance, can absorb moisture from the environment and supplement the moisture to the skin, can further improve the moisturizing effect of the jelly-shaped eye shadow, keeps the jelly shape, and is also beneficial to moisturizing the deep skin layer of the jelly-shaped eye shadow.
In some embodiments, the stabilizing agent is selected from the group consisting of anhydrous calcium chloride, potassium laurate, magnesium sulfate, sodium chloride, potassium chloride, tromethamine, triethanolamine, or a combination thereof. The stability of jelly shape can be improved by adding the stabilizer.
In some embodiments, the jelly-like eye shadow further comprises 0.5% to 1.5% of a powder dispersant and/or 0.02% to 0.3% of an antioxidant. According to the embodiment of the application, the antioxidant can reduce the oxidation of the coloring powder, reduce the color change of the eye shadow and improve the cosmetic property of the eye shadow; it also can be used for resisting harmful free radicals which can damage skin, such as vitamin C can be used for resisting free radicals, and improving overall appearance of skin.
Preparation method of jelly-shaped eye shadow
In a second aspect, an embodiment of the present application provides a method for preparing a jelly-like eye shadow, including:
providing components and component amounts of an eye shadow according to the first aspect;
preparing a filling material: mixing and dispersing 10% -18% of pearl powder and 5% -12% of coloring powder to obtain uniform filler;
preparing a functional material in a liquid state: mixing 0.5-3% of aqueous thickening agent, 0.2-1% of emollient oil, 0.02-0.2% of oil-in-water emulsifier, 0.02-0.3% of stabilizer, 4-6% of humectant and 65-78% of water at a predetermined temperature to obtain a liquid functional material;
preparing an eye shadow: mixing and emulsifying the filling material and the functional material in the liquid state to obtain the jelly-shaped eye shadow;
optionally, the preparation of the filler is performed simultaneously with the preparation of the functional material in a liquid state. In some embodiments, preparing the filler is performed simultaneously with preparing the functional material in a liquid state. The purpose of improving efficiency can be achieved.
In some embodiments, the predetermined temperature is 30-150 ℃, optionally 50-100 ℃. The binder can be made liquid and mixed with the vegetable fat or oil.
According to the embodiment of the application, by controlling the stirring speed, the components can be uniformly dispersed, and meanwhile, the dispersion efficiency is improved; the attachments attached in the container are collected and utilized, so that the raw materials can be saved, and the mass ratio of each component can be fully controlled.
Examples
The present disclosure is more particularly described in the following examples that are intended as illustrative only, since various modifications and changes within the scope of the present disclosure will be apparent to those skilled in the art. Unless otherwise indicated, all parts, percentages, and ratios reported in the following examples are on a weight basis, and all reagents used in the examples are commercially available or synthesized according to conventional methods and can be used directly without further treatment, and the equipment used in the examples is commercially available.
Examples 1 to 3
The jelly-like eye shadow comprises the following components in percentage by mass:
10-18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica;
coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, black iron oxide, at least part of the surface of which is coated by silica;
0.5 to 3 percent of aqueous thickening agent;
0.2-1% of emollient oil;
0.02-0.2% of oil-in-water emulsifier
0.02% -0.3% of stabilizer;
4% -6% of a humectant;
65 to 78 percent of water.
The components and component amounts in the examples are shown in table 1.
The preparation method of the jelly-shaped eye shadow comprises the following steps:
providing materials according to the components and the component content of the eye shadow;
preparing a filling material: mixing and dispersing 10% -18% of pearl powder and 5% -12% of coloring powder to obtain uniform filler;
preparing a functional material in a liquid state: mixing 0.5-3% of aqueous thickening agent, 0.2-1% of emollient oil, 0.02-0.2% of oil-in-water emulsifier, 0.02-0.3% of stabilizer, 4-6% of humectant and 65-78% of water at a predetermined temperature to obtain a liquid functional material;
preparing an eye shadow: and mixing and emulsifying the filling material and the functional material in the liquid state to obtain the jelly-shaped eye shadow.
Checking color and uniformity, and repeating the above operations if the color and uniformity are not satisfactory; and transferring the material body to a container to be protected from light after meeting the requirements.
TABLE 1
Comparative examples 1 to 7
The comparative example of the application provides an eye shadow, the difference lies in: the composition and content of the eye shadow were the same as those in example 1. The comparative example components and component amounts are shown in table 2.
TABLE 2
Performance detection
1) Patch test
30 persons (5 men, 25 women) were drawn, aged from 18 to 60 years, and the following conditions should be excluded from the subjects.
The pregnant woman or lactation woman.
Extremely sensitive skin.
And that the antihistamine or immunosuppression has been within one month within one week.
The patch part is patched within 2 months by the anti-inflammatory agent.
The subject matter of fifthly does not treat inflammatory skin diseases.
Sixthly, insulin is used by the subject matter of diabetes.
The asthma-related or CRD subjects are receiving treatment.
And curing the cancer within 6 months by adopting chemotherapy.
A self-autoimmune disease.
Bilateral mastectomy with bilateral axillary lymphadenectomy.
Those operating in the same or similar professions.
Those traces, flaws or moles are left in the test area.
The references are those who are unwilling to participate in the test or unable to complete the test as desired.
The spot pasting test is carried out by the specific method: an amount of 0.2g of the eye shadow prepared in example was applied to the anterior-medial side of the arm over a skin area of 2cm × 2cm for 0.5h, 24h and 48h, and the skin reaction results were recorded as shown in Table 3.
Table 3 patch test results.
None of the 30 persons had an allergic reaction to the product according to the above test, and the product was adapted to most consumers.
2) Observation of eye shadow State Change of example
Changes in the eye shadow prepared in the examples were observed, and the results are shown in table 4 below.
Item | Example 1 | Example 2 | Example 3 |
1 day | Stabilization of | Stabilization | Stabilization of |
7 days | Stabilization | Stabilization of | Stabilization |
14 days | Stabilization | Stabilization | Stabilization of |
1 month | Stabilization | Stabilization | Stabilization |
As shown in table 4, examples 1-3 were also stable after one month of preparation by observing the stability of the eye shadows of the examples and comparative examples at room temperature for one month.
Comparative examples 2 to 6 did not produce the jelly-like shape of the present application, and at 7 days, the eye shadow state was changed and unstable. In comparative examples 3-4, separation was observed after 14. The reason for the jelly separation phenomenon in the comparative example is that a suitable oil-in-water emulsifier was not added.
As shown in fig. 1, in the embodiment, it was confirmed that the liquid did not flow down when the eye shadow was used, and the part remained in the non-fallen jelly-like state.
As shown in fig. 2, in comparative example 3, a large number of smears were shown immediately after use, and comparative example 2 was not fixed during spraying, and the liquid flowed downward, and thus it was confirmed that it was not provided with a jelly-like shape.
3) Sensory evaluation test
Subjects: healthy Chinese females in 25-45 years old in the same area, which have no obvious wounds and diseases on the face and dry cheekbone parts, are recruited, 20 females in each experimental group, and the average value of the experimental results is rounded.
The experimental method comprises the following steps:
experimental groups: the face was cleansed at 8 am, and then 0.2g of the eye shadow of the examples and comparative examples was applied to the cheekbone portion of the right cheek.
And (3) grading rules: the subjects scored the following parameters, respectively:
grading the stereoscopic impression: has better stereoscopic effect, marked as '1', and the poor stereoscopic effect is marked as '0'.
Grading the degree of darkness: after the eye shadow is made up for 5.5h, observing whether the eye shadow has a dark condition, wherein the dark condition is marked as '1' when the eye shadow does not have the dark condition, and the dark condition is marked as '0' when the eye shadow has the dark condition;
the degree of dripping was scored as the degree of slipping or dripping of the eye shadow when applied to the skin using 0.2ml of eye shadow on a 45 degree slope from the plane of the skin. No drip is '1', and slip or drip is '0';
make-up remaining degree test:
after the smearing of the experimental objects is finished, running the experimental objects by a running machine at the temperature of 35 ℃, wherein the running speed is 10km/h, and after running for 10min, the experimental objects all have a sweating condition; resting for 10min after running for 20 min; after 3 hours, stopping movement, observing the makeup removing condition, wherein the makeup removing degree is smaller, the score is higher, and the full score is 10 parts; the higher the degree of makeup removal, the lower the score.
TABLE 4
The eye shadow of the examples 1 to 3 had good stereoscopic impression, was resistant to darkness, did not drip the jelly-like eye shadow, and had good makeup-holding property. Comparative example 1, in which no silica was added, had poor color dispersion and poor stereoscopic effect, had a certain anti-darkening effect, but was relatively low. The makeup retention degree is slightly reduced due to poor color dispersion.
Comparative example 2 to comparative example 6 No hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate, gellan gum, PEG-240/HDI copolymer bis-decyltetradecanol polyether-20 ether were added, no jelly was formed, and various properties were slightly degraded.
In comparative example 7, sodium calcium borosilicate, tin oxide and the like were not added, and the skin was dark, and the skin secreted much oil and fat, and had poor long-lasting makeup.
While the invention has been described with reference to specific embodiments, the scope of the invention is not limited thereto, and those skilled in the art can easily conceive various equivalent modifications or substitutions within the technical scope of the invention. Therefore, the protection scope of the present application shall be subject to the protection scope of the claims.
Claims (10)
1. A jelly-like eye shadow comprises the following components in percentage by mass:
10-18% of pearl powder, which comprises at least one of calcium aluminum borosilicate, calcium sodium borosilicate and mica;
coloring powder, 5% -12%, comprising titanium dioxide powder, tin oxide, iron oxide black, wherein at least part of the surface of the titanium dioxide powder is coated by silica;
0.5 to 3 percent of aqueous thickening agent;
0.2 to 1 percent of emollient oil;
0.02-0.2% of oil-in-water emulsifier
0.02% -0.3% of stabilizer;
4% -6% of a humectant;
65 to 78 percent of water.
2. The jelly-like eye shadow according to claim 1, characterized in that the pearlescent powder comprises 80-92% of calcium sodium borosilicate and 8-20% of mica, based on the total weight of the pearlescent powder; and/or the presence of a gas in the gas,
the colored powder comprises 35 to 45% of titanium dioxide powder partially surface-coated with silica, based on the total weight of the colored powder.
3. Jelly-like eye shadow according to claim 1 or 2, characterized in that the aqueous thickener is selected from gellan gum, carrageenan, PEG-240/HDI copolymer bis-decyltetradecylpolyether-20 ether or a combination thereof.
4. The jelly-like eye shadow of claim 3, wherein the aqueous thickener comprises 60 to 75% gellan gum based on the total weight of the aqueous thickener.
5. Eye shadow according to claim 4, characterized in that the mass ratio between the gellan gum and the PEG-240/HDI copolymer bis-decyltetradecanolpolyether-20 ether is (25-32): 50, optionally 29.94:50.
6. an eye shadow according to claim 1 or 2, wherein the oil-in-water emulsifier is selected from hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, polysorbate-60, sorbitan isostearate or combinations thereof.
7. The eye shadow of claim 6, wherein the mass ratio of the hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, the polysorbate-60 and the sorbitan isostearate is (42-46): (2-4): 3, optionally 44.
8. The jelly-like eye shadow of claim 1 or 2, wherein the emollient oil is selected from polydimethylsiloxane, macadamia nut ethyl oleate, hydrogenated coconut oil glycerides, glyceryl laurate, isononyl isononanoate, hydrogenated polyisobutene, sunflower seed oil, safflower seed oil, jojoba oil, castor oil, coconut oil, grape seed oil, shea butter, meadowfoam seed oil, macadamia nut oil, olive oil, palm oil or combinations thereof; and/or the presence of a gas in the atmosphere,
the humectant is selected from glycerol, propylene glycol, 1, 3-butanediol, trehalose, tremella polysaccharide, magnetitum, sodium hyaluronate or their combination; and/or the presence of a gas in the gas,
the preservative is selected from phenoxyethanol, caprylyl glycol, sodium benzoate, glyceryl caprylate, anisic acid, cortex Magnolia officinalis extract or a combination thereof; and/or the presence of a gas in the gas,
the stabilizer is selected from anhydrous calcium chloride, potassium laurate, magnesium sulfate, sodium chloride, potassium chloride, tromethamine, triethanolamine, or a combination thereof.
9. The eye shadow of claim 1 or 2, wherein the jelly-like eye shadow further comprises 0.5% to 1.5% of a powder dispersant and/or 0.02% to 0.3% of an antioxidant.
10. A method for preparing a jelly-like eye shadow, comprising:
a component for providing an eye shadow according to any one of claims 1 to 9 and the amount of the component;
preparing a filling material: mixing and dispersing 10% -18% of pearl powder and 5% -12% of coloring powder to obtain uniform filler;
preparing a functional material in a liquid state: mixing 0.5-3% of aqueous thickening agent, 0.2-1% of emollient oil, 0.02-0.2% of oil-in-water emulsifier, 0.02-0.3% of stabilizer, 4-6% of humectant and 65-78% of water at a predetermined temperature to obtain a liquid functional material;
preparing an eye shadow: mixing and emulsifying the filling material and the functional material in the liquid state to obtain the eye shadow;
optionally, the preparation of the filler is performed simultaneously with the preparation of the functional material in a liquid state.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211660883.XA CN115778847B (en) | 2022-12-23 | 2022-12-23 | Jelly-like eye shadow and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211660883.XA CN115778847B (en) | 2022-12-23 | 2022-12-23 | Jelly-like eye shadow and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115778847A true CN115778847A (en) | 2023-03-14 |
CN115778847B CN115778847B (en) | 2024-01-09 |
Family
ID=85427763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211660883.XA Active CN115778847B (en) | 2022-12-23 | 2022-12-23 | Jelly-like eye shadow and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115778847B (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002146237A (en) * | 2000-11-15 | 2002-05-22 | Arie:Kk | Novel color iris foil gloss pigment and cosmetic comprising the same |
KR20070081994A (en) * | 2006-03-21 | 2007-08-20 | 주식회사 엘지생활건강 | Cosmetic composition for make-up of stick-type providing refreshing feeling and pearl feeling and preparation method thereof |
CN107320395A (en) * | 2017-08-14 | 2017-11-07 | 上海欧润化妆品有限公司 | A kind of eye shadow and preparation method thereof |
CN107412115A (en) * | 2017-02-09 | 2017-12-01 | 苏州安特化妆品股份有限公司 | A kind of g., jelly-like foundation cream and preparation method thereof |
CN107737025A (en) * | 2017-10-27 | 2018-02-27 | 新时代健康产业(集团)有限公司 | A kind of velvet gel moisturizing eye shadow and preparation method thereof |
CN113520889A (en) * | 2020-04-21 | 2021-10-22 | 上海瀛彩生物科技有限公司 | Pearlescent eye shadow gel powder and preparation method thereof |
CN115300417A (en) * | 2022-09-16 | 2022-11-08 | 诺斯贝尔化妆品股份有限公司 | Sunscreen cream suitable for children and sensitive muscles and preparation method thereof |
-
2022
- 2022-12-23 CN CN202211660883.XA patent/CN115778847B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002146237A (en) * | 2000-11-15 | 2002-05-22 | Arie:Kk | Novel color iris foil gloss pigment and cosmetic comprising the same |
KR20070081994A (en) * | 2006-03-21 | 2007-08-20 | 주식회사 엘지생활건강 | Cosmetic composition for make-up of stick-type providing refreshing feeling and pearl feeling and preparation method thereof |
CN107412115A (en) * | 2017-02-09 | 2017-12-01 | 苏州安特化妆品股份有限公司 | A kind of g., jelly-like foundation cream and preparation method thereof |
CN107320395A (en) * | 2017-08-14 | 2017-11-07 | 上海欧润化妆品有限公司 | A kind of eye shadow and preparation method thereof |
CN107737025A (en) * | 2017-10-27 | 2018-02-27 | 新时代健康产业(集团)有限公司 | A kind of velvet gel moisturizing eye shadow and preparation method thereof |
CN113520889A (en) * | 2020-04-21 | 2021-10-22 | 上海瀛彩生物科技有限公司 | Pearlescent eye shadow gel powder and preparation method thereof |
CN115300417A (en) * | 2022-09-16 | 2022-11-08 | 诺斯贝尔化妆品股份有限公司 | Sunscreen cream suitable for children and sensitive muscles and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
国产普通化妆品备案信息: "Jelly Bubble 果冻泡弹眼影03荆棘蔷薇", pages 1, Retrieved from the Internet <URL:https://hzpba.nmpa.gov.cn/gccx/chakan.html?prodId=1019932104416296960&gb=G> * |
国产普通化妆品备案信息: "星糖闪光时刻果冻眼影「甜心钻石」", pages 1, Retrieved from the Internet <URL:https://hzpba.nmpa.gov.cn/gccx/chakanHis.html?prodId=201908011624512g9ui&gb=G> * |
Also Published As
Publication number | Publication date |
---|---|
CN115778847B (en) | 2024-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110946771A (en) | Water-containing oil-controlling loose powder and preparation method thereof | |
CN109846738A (en) | A kind of formula and preparation method thereof of moisturizing lipstick | |
KR101811849B1 (en) | Cosmetic compositions with improved moisturizer and transfer resistant ability for long lasting concealing effect | |
CN111643401B (en) | Lipstick with high water content and preparation method thereof | |
CN111096912B (en) | Bicontinuous phase type eye and lip makeup remover and preparation method thereof | |
CN109044889B (en) | Glossy and smooth matte lipstick and production process thereof | |
CN114028267B (en) | Oil-control make-up-fixing composition, water-containing honey powder and preparation method thereof | |
KR101794555B1 (en) | Cosmetic composition for protecting lip comprising natural ceramide and rosa canina fruit oil | |
CN108888524B (en) | Concealer composition and process for producing the same | |
CN110507562B (en) | Light sensation concealer CC cream and preparation method thereof | |
CN112656729A (en) | Oil control isolation composition and preparation method and application thereof | |
CN115337249A (en) | Matte eye shadow and preparation method thereof | |
KR20010072740A (en) | Solid aqueous gel comprising a hydrophilic gelling agent and starch, composition comprising same and uses | |
CN109431956B (en) | Matte lip glaze and preparation process thereof | |
CN113425650A (en) | Oil control composition containing plant active ingredients | |
CN112274438A (en) | Eyebrow-holding type correction cream and preparation method thereof | |
CN109199984B (en) | Whitening and skin-care composition capable of changing powder into cream and preparation method thereof | |
CN115778847B (en) | Jelly-like eye shadow and preparation method thereof | |
CN115400035A (en) | Pearlescent eye shadow and preparation method thereof | |
CN113081872B (en) | Moistening and lasting lipstick | |
KR101684415B1 (en) | Cosmetic composition of water-in-oil with liposome hexacarboxymethyl dipeptide-12 and menufacturing method thereof | |
KR101472315B1 (en) | Eye liner of cream form cosmetic composition comprising hectorit and fine grinding pigment | |
CN109157493B (en) | Lip scrub cream and preparation method thereof | |
KR20210036837A (en) | Sunscreen composition containing cerium oxide flake and inorganic uv-screening agent particle | |
KR101183068B1 (en) | The components of cosmetics with positive |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |